Bayer Pharmaceutical facing 78 Trasylol lawsuits in U.S.
COLOGNE, Germany – Bayer’s CEO stated that Bayer AG is facing 78 Trasylol lawsuits in the United States as a result of its heart surgery drug. “We are not aware of any lawsuit outside the United States,” Werner Wenning told a shareholders’ meeting.
Each year approximately one million patients undergo surgery following a heart attack. Prior to Trasylol being withdrawn from the marketplace, the majority of patients who were at increased risk of bleeding during surgery had the option of one of three antifibrinolytic drugs to limit blood loss: Trasylol (Aprotinin), Amicar (aminocaproic acid), or Cyklokapron (tranexamic acid). These drugs work by inactivating an enzyme called plasmin so it stops from breaking down blood clots which helps prevent bleeding.
Bayer’s Trasylol heart surgery side effects have recently been linked to an increased rate of kidney failure, heart attack, and death in the five years following a patient undergoing heart surgery.
In November 2007, Bayer withdrew Trasylol from the marketplace following a Canadian study that associated Trasylol with an increased risk of death and kidney failure. Bayer plans on defending Trasylol claims vigorously, however time will tell how they deal with potentially thousands of claims from individuals and families throughout the country as litigation continues.
We are a Law Firm that is dedicated to helping people who have been affected by Trasylol side effects.
Personal Injury Law Firm
- Trasylol Lawsuit News | Aprotinin Heart Surgery Drugs Renal Failure
- Surgery Trasylol Law Suit News | Trasylol Lawyer
- Trasylol Lawsuits | Trasylol Bayer News
- Aprotinin Drug Trasylol | Class Action Lawsuit
- Class Action Trasylol Updates | Heart Surgery Drug
- Trasylol Side Effects | Trasylol Litigation News
- Trasylol Lawsuit News | Trasylol Recall
Bayer HealthCare Pharmaceuticals, Inc. has been facing an increasing number of patients who have filed a Trasylol lawsuit over its Aprotinin heart surgery drug. The lawsuits allege that Bayer is liable for manufacturing and failing to warn Trasylol users of its dangerous side effects. The Trasylol lawsuits allege that Bayer knew Trasylol increases patients’ risk [...]
Until recently, Bayer’s anti-bleeding drug was used on a regular basis during heart surgery. Trasylol (Aprotinin) is widely used to decrease bleeding risk during coronary artery bypass graft (CABG) surgery. There are some common side effects that persist or become bothersome following use, including: constipation, diarrhea, difficulty urinating, infection (fever, chills, sore throat), lightheadedness, sleeplessness [...]
We represent all Trasylol lawsuits clients on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call toll free at 1-888-343-5375 or fill out our short online contact form and a Trasylol lawyer will contact you to answer any of [...]
Trasylol Aprotinin Side Effects Study
Another study reveals an increased risk of serious Trasylol side effects leading to a higher mortality rate in aprotinin bypass patients. A recent study published in The New England Journal of Medicine on February 21, 2008 shows an increased risk of death for patients receiving aprotinin (Trasylol) during coronary-artery bypass grafting [...]
Trasylol Heart Surgery Drug Information
What is aprotinin injection?
APROTININ (Trasylol) is a drug that affects the way blood clots. It was given to heart surgery patients during bypass procedures. Aprotinin was mainly used during repeat coronary artery bypass surgery to reduce the amount of bleeding before and after surgery. Trasylol and other clotting medications help to [...]
